FDA Inspection 1310416 - Sunrise Pharmaceutical, Inc. - March 31, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Sunrise Pharmaceutical, Inc., with an inspection on March 31, 2026, issued by the New Jersey District Office, covering human drugs.

Company: Sunrise Pharmaceutical, Inc.
Inspection Date: March 31, 2026
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · 134a0df6-db17-42bb-a748-6fdef717a55f

Violation Codes1

21 CFR 211.142(b)

Full citation text and observation details available on the Dashboard.